How common is pseudoprogression in glioblastoma

How common is pseudoprogression in glioblastoma? 

Twenty to thirty percent of patients undergoing their first postchemoradiation MRI show increased contrast enhancement that ultimately resolves without any change in therapy.

Are there any radiographic criteria to determine tumor progression? 

The Response Assessment in Neuro-Oncology (RANO) criteria are used, which incorporates an increase in fluid attenuated inversion recovery hyperintensity as a way to measure nonenhancing tumor progression.

15585

Sign up to receive the trending updates and tons of Health Tips

Join SeekhealthZ and never miss the latest health information

15856